Global and United States Glutamate Receptor Ionotropic NMDA 2B Market Report & Forecast 2024-2031

Report ID: 1839034 | Published Date: Oct 2024 | No. of Page: 94 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
1 Study Coverage
    1.1 Glutamate Receptor Ionotropic NMDA 2B Product Introduction
    1.2 Global Glutamate Receptor Ionotropic NMDA 2B Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume for the Year 2017-2028
    1.3 United States Glutamate Receptor Ionotropic NMDA 2B Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Glutamate Receptor Ionotropic NMDA 2B Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Glutamate Receptor Ionotropic NMDA 2B Sales in Volume for the Year 2017-2028
    1.4 Glutamate Receptor Ionotropic NMDA 2B Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Glutamate Receptor Ionotropic NMDA 2B in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Glutamate Receptor Ionotropic NMDA 2B Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Glutamate Receptor Ionotropic NMDA 2B Market Dynamics
        1.5.1 Glutamate Receptor Ionotropic NMDA 2B Industry Trends
        1.5.2 Glutamate Receptor Ionotropic NMDA 2B Market Drivers
        1.5.3 Glutamate Receptor Ionotropic NMDA 2B Market Challenges
        1.5.4 Glutamate Receptor Ionotropic NMDA 2B Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Glutamate Receptor Ionotropic NMDA 2B Market Segment by Type
        2.1.1 JNJ-0808
        2.1.2 Neu-2000
        2.1.3 NP-10679
        2.1.4 NP-11948
        2.1.5 Radiprodil
        2.1.6 Others
    2.2 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Type
        2.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Glutamate Receptor Ionotropic NMDA 2B Market Size by Type
        2.3.1 United States Glutamate Receptor Ionotropic NMDA 2B Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Glutamate Receptor Ionotropic NMDA 2B Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Glutamate Receptor Ionotropic NMDA 2B Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Glutamate Receptor Ionotropic NMDA 2B Market Segment by Application
        3.1.1 Acute Ischemic Stroke
        3.1.2 Autism
        3.1.3 Brain Ischemia
        3.1.4 Burns
        3.1.5 Others
    3.2 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Application
        3.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Glutamate Receptor Ionotropic NMDA 2B Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Glutamate Receptor Ionotropic NMDA 2B Market Size by Application
        3.3.1 United States Glutamate Receptor Ionotropic NMDA 2B Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Glutamate Receptor Ionotropic NMDA 2B Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Glutamate Receptor Ionotropic NMDA 2B Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Glutamate Receptor Ionotropic NMDA 2B Competitor Landscape by Company
    4.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Company
        4.1.1 Top Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturer (2017-2022)
        4.1.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturer (2017-2022)
        4.1.4 Global Glutamate Receptor Ionotropic NMDA 2B Price by Manufacturer (2017-2022)
    4.2 Global Glutamate Receptor Ionotropic NMDA 2B Concentration Ratio (CR)
        4.2.1 Glutamate Receptor Ionotropic NMDA 2B Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Glutamate Receptor Ionotropic NMDA 2B in 2021
        4.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base Distribution, Product Type
        4.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Glutamate Receptor Ionotropic NMDA 2B Product Type
        4.3.3 Date of International Manufacturers Enter into Glutamate Receptor Ionotropic NMDA 2B Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Glutamate Receptor Ionotropic NMDA 2B Market Size by Company
        4.5.1 Top Glutamate Receptor Ionotropic NMDA 2B Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Glutamate Receptor Ionotropic NMDA 2B Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Glutamate Receptor Ionotropic NMDA 2B Sales by Players (2020, 2021 & 2022)
5 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Region
    5.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Glutamate Receptor Ionotropic NMDA 2B Market Size in Volume by Region (2017-2028)
        5.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Region: 2017-2022
        5.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Size in Value by Region (2017-2028)
        5.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Region: 2017-2022
        5.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2017-2028
        6.1.2 North America Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2017-2028
        6.3.2 Europe Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2017-2028
        6.4.2 Latin America Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 BioCrea GmbH
        7.1.1 BioCrea GmbH Corporation Information
        7.1.2 BioCrea GmbH Description and Business Overview
        7.1.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Products Offered
        7.1.5 BioCrea GmbH Recent Development
    7.2 Bristol-Myers Squibb Company
        7.2.1 Bristol-Myers Squibb Company Corporation Information
        7.2.2 Bristol-Myers Squibb Company Description and Business Overview
        7.2.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Products Offered
        7.2.5 Bristol-Myers Squibb Company Recent Development
    7.3 Cerecor Inc.
        7.3.1 Cerecor Inc. Corporation Information
        7.3.2 Cerecor Inc. Description and Business Overview
        7.3.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Products Offered
        7.3.5 Cerecor Inc. Recent Development
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Corporation Information
        7.4.2 Johnson & Johnson Description and Business Overview
        7.4.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Products Offered
        7.4.5 Johnson & Johnson Recent Development
    7.5 Luc Therapeutics, Inc.
        7.5.1 Luc Therapeutics, Inc. Corporation Information
        7.5.2 Luc Therapeutics, Inc. Description and Business Overview
        7.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Products Offered
        7.5.5 Luc Therapeutics, Inc. Recent Development
    7.6 NeurOp, Inc
        7.6.1 NeurOp, Inc Corporation Information
        7.6.2 NeurOp, Inc Description and Business Overview
        7.6.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Products Offered
        7.6.5 NeurOp, Inc Recent Development
    7.7 Novartis AG
        7.7.1 Novartis AG Corporation Information
        7.7.2 Novartis AG Description and Business Overview
        7.7.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Products Offered
        7.7.5 Novartis AG Recent Development
    7.8 UCB S.A.
        7.8.1 UCB S.A. Corporation Information
        7.8.2 UCB S.A. Description and Business Overview
        7.8.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Products Offered
        7.8.5 UCB S.A. Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Glutamate Receptor Ionotropic NMDA 2B Industry Chain Analysis
    8.2 Glutamate Receptor Ionotropic NMDA 2B Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Glutamate Receptor Ionotropic NMDA 2B Distributors
    8.3 Glutamate Receptor Ionotropic NMDA 2B Production Mode & Process
    8.4 Glutamate Receptor Ionotropic NMDA 2B Sales and Marketing
        8.4.1 Glutamate Receptor Ionotropic NMDA 2B Sales Channels
        8.4.2 Glutamate Receptor Ionotropic NMDA 2B Distributors
    8.5 Glutamate Receptor Ionotropic NMDA 2B Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer
List of Tables
    Table 1. Glutamate Receptor Ionotropic NMDA 2B CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Glutamate Receptor Ionotropic NMDA 2B Market Trends
    Table 3. Glutamate Receptor Ionotropic NMDA 2B Market Drivers
    Table 4. Glutamate Receptor Ionotropic NMDA 2B Market Challenges
    Table 5. Glutamate Receptor Ionotropic NMDA 2B Market Restraints
    Table 6. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Glutamate Receptor Ionotropic NMDA 2B Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Glutamate Receptor Ionotropic NMDA 2B Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Glutamate Receptor Ionotropic NMDA 2B Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Glutamate Receptor Ionotropic NMDA 2B Sales Share by Manufacturer, 2017-2022
    Table 15. Global Glutamate Receptor Ionotropic NMDA 2B Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Glutamate Receptor Ionotropic NMDA 2B Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Glutamate Receptor Ionotropic NMDA 2B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glutamate Receptor Ionotropic NMDA 2B as of 2021)
    Table 18. Top Players of Glutamate Receptor Ionotropic NMDA 2B in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Glutamate Receptor Ionotropic NMDA 2B Product Type
    Table 20. Date of International Manufacturers Enter into Glutamate Receptor Ionotropic NMDA 2B Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Glutamate Receptor Ionotropic NMDA 2B Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Glutamate Receptor Ionotropic NMDA 2B Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Glutamate Receptor Ionotropic NMDA 2B Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Glutamate Receptor Ionotropic NMDA 2B Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Glutamate Receptor Ionotropic NMDA 2B Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. BioCrea GmbH Corporation Information
    Table 43. BioCrea GmbH Description and Business Overview
    Table 44. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product
    Table 46. BioCrea GmbH Recent Development
    Table 47. Bristol-Myers Squibb Company Corporation Information
    Table 48. Bristol-Myers Squibb Company Description and Business Overview
    Table 49. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Bristol-Myers Squibb Company Product
    Table 51. Bristol-Myers Squibb Company Recent Development
    Table 52. Cerecor Inc. Corporation Information
    Table 53. Cerecor Inc. Description and Business Overview
    Table 54. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Cerecor Inc. Product
    Table 56. Cerecor Inc. Recent Development
    Table 57. Johnson & Johnson Corporation Information
    Table 58. Johnson & Johnson Description and Business Overview
    Table 59. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Johnson & Johnson Product
    Table 61. Johnson & Johnson Recent Development
    Table 62. Luc Therapeutics, Inc. Corporation Information
    Table 63. Luc Therapeutics, Inc. Description and Business Overview
    Table 64. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Luc Therapeutics, Inc. Product
    Table 66. Luc Therapeutics, Inc. Recent Development
    Table 67. NeurOp, Inc Corporation Information
    Table 68. NeurOp, Inc Description and Business Overview
    Table 69. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. NeurOp, Inc Product
    Table 71. NeurOp, Inc Recent Development
    Table 72. Novartis AG Corporation Information
    Table 73. Novartis AG Description and Business Overview
    Table 74. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Novartis AG Product
    Table 76. Novartis AG Recent Development
    Table 77. UCB S.A. Corporation Information
    Table 78. UCB S.A. Description and Business Overview
    Table 79. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. UCB S.A. Product
    Table 81. UCB S.A. Recent Development
    Table 82. Key Raw Materials Lists
    Table 83. Raw Materials Key Suppliers Lists
    Table 84. Glutamate Receptor Ionotropic NMDA 2B Customers List
    Table 85. Glutamate Receptor Ionotropic NMDA 2B Distributors List
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Glutamate Receptor Ionotropic NMDA 2B Product Picture
    Figure 2. Global Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Glutamate Receptor Ionotropic NMDA 2B Market Size 2017-2028 (US$ Million)
    Figure 4. Global Glutamate Receptor Ionotropic NMDA 2B Sales 2017-2028 (K Pcs)
    Figure 5. United States Glutamate Receptor Ionotropic NMDA 2B Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Glutamate Receptor Ionotropic NMDA 2B Market Size 2017-2028 (US$ Million)
    Figure 7. United States Glutamate Receptor Ionotropic NMDA 2B Sales 2017-2028 (K Pcs)
    Figure 8. United States Glutamate Receptor Ionotropic NMDA 2B Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Glutamate Receptor Ionotropic NMDA 2B Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Glutamate Receptor Ionotropic NMDA 2B Report Years Considered
    Figure 11. Product Picture of JNJ-0808
    Figure 12. Product Picture of Neu-2000
    Figure 13. Product Picture of NP-10679
    Figure 14. Product Picture of NP-11948
    Figure 15. Product Picture of Radiprodil
    Figure 16. Product Picture of Others
    Figure 17. Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Type in 2022 & 2028
    Figure 18. Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 19. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Type (2017-2028)
    Figure 20. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2028) & (K Pcs)
    Figure 21. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type (2017-2028)
    Figure 22. Global Glutamate Receptor Ionotropic NMDA 2B Price by Type (2017-2028) & (USD/Pcs)
    Figure 23. United States Glutamate Receptor Ionotropic NMDA 2B Market Share by Type in 2022 & 2028
    Figure 24. United States Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 25. United States Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Type (2017-2028)
    Figure 26. United States Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2028) & (K Pcs)
    Figure 27. United States Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Type (2017-2028)
    Figure 28. United States Glutamate Receptor Ionotropic NMDA 2B Price by Type (2017-2028) & (USD/Pcs)
    Figure 29. Product Picture of Acute Ischemic Stroke
    Figure 30. Product Picture of Autism
    Figure 31. Product Picture of Brain Ischemia
    Figure 32. Product Picture of Burns
    Figure 33. Product Picture of Others
    Figure 34. Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Application in 2022 & 2028
    Figure 35. Global Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application (2017-2028)
    Figure 37. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2028) & (K Pcs)
    Figure 38. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Application (2017-2028)
    Figure 39. Global Glutamate Receptor Ionotropic NMDA 2B Price by Application (2017-2028) & (USD/Pcs)
    Figure 40. United States Glutamate Receptor Ionotropic NMDA 2B Market Share by Application in 2022 & 2028
    Figure 41. United States Glutamate Receptor Ionotropic NMDA 2B Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 42. United States Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Value by Application (2017-2028)
    Figure 43. United States Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2028) & (K Pcs)
    Figure 44. United States Glutamate Receptor Ionotropic NMDA 2B Sales Market Share in Volume by Application (2017-2028)
    Figure 45. United States Glutamate Receptor Ionotropic NMDA 2B Price by Application (2017-2028) & (USD/Pcs)
    Figure 46. North America Glutamate Receptor Ionotropic NMDA 2B Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 47. North America Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. U.S. Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Canada Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Europe Glutamate Receptor Ionotropic NMDA 2B Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 51. Europe Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. Germany Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. France Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.K. Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Italy Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Russia Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 58. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 59. China Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Japan Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. South Korea Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. India Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Australia Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Taiwan Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Indonesia Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Thailand Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Malaysia Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Philippines Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 70. Latin America Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Mexico Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Brazil Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Argentina Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 75. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 76. Turkey Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. Saudi Arabia Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. U.A.E Glutamate Receptor Ionotropic NMDA 2B Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 79. Glutamate Receptor Ionotropic NMDA 2B Value Chain
    Figure 80. Glutamate Receptor Ionotropic NMDA 2B Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BioCrea GmbH
Bristol-Myers Squibb Company
Cerecor Inc.
Johnson & Johnson
Luc Therapeutics, Inc.
NeurOp, Inc
Novartis AG
UCB S.A.
Frequently Asked Questions
Glutamate Receptor Ionotropic NMDA 2B report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Glutamate Receptor Ionotropic NMDA 2B report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Glutamate Receptor Ionotropic NMDA 2B report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Vanadium Target

Vanadium Target market is segmented by region (country), players, by Type and by Application. Pla ... Read More

Vegetable Chutney

Vegetable Chutney market is segmented by region (country), players, by Type and by Application. P ... Read More